[O.T.] Tra i due litiganti, il terzo COVID

Scatta il fluido erotico...

Moderatori: Super Zeta, AlexSmith, Pim, Moderatore1

Messaggio
Autore
Ignatius
Bannato
Bannato
Messaggi: 433
Iscritto il: 20/07/2022, 13:29

Re: [O.T.] Tra i due litiganti, il terzo COVID

#13141 Messaggio da Ignatius »

GeishaBalls ha scritto:
01/02/2023, 21:36
dboon ha scritto:
01/02/2023, 21:16

Pfizer: ricavi 2022 record oltre 100 miliardi dollari

https://www.ansa.it/sito/notizie/econom ... 67f33.html
Un quarto di Apple
'na caccola (cit)

Ignatius
Bannato
Bannato
Messaggi: 433
Iscritto il: 20/07/2022, 13:29

Re: [O.T.] Tra i due litiganti, il terzo COVID

#13142 Messaggio da Ignatius »



ma che cazz :lol: :lol:

Ignatius
Bannato
Bannato
Messaggi: 433
Iscritto il: 20/07/2022, 13:29

Re: [O.T.] Tra i due litiganti, il terzo COVID

#13143 Messaggio da Ignatius »

Floppy Disk ha scritto:
20/01/2023, 19:51
Leggendo la ricerca, mi pare si possa mettere la parola fine a tante chiacchiere, illazioni e teorie più o meno assurde sul fatto che i vaccini siano stati devastanti per la salute e abbiano creato problemi per le generazioni future, quando in realtà hanno fatto l'esatto opposto vista la situazione. Posto un passaggio abbastanza esemplificativo.
[Scopri]Spoiler
In the entire population of an Italian province, followed for an average of 14 months, subjects who received one or more doses of COVID-19 vaccines did not show an increased risk of death from any cause, death unrelated to SARS-CoV-2 infection, or any of the recorded potentially vaccine-related serious adverse events requiring hospitalization. Furthermore, some of the outcomes (all-cause mortality, and incidence of stroke, cardiac arrest, thrombosis, and pulmonary embolism) were significantly less frequent among the vaccinated. These findings were consistent across genders, age-classes, most frequently administered vaccine types, and SARS-CoV-2 infection status and remained so after adjusting for previous episodes of disease and several potential confounders. Importantly, strikingly different results were observed in the uninfected population, between subjects who received three or more doses and those who received only one or two doses. The latter groups showed a significantly higher incidence of most outcomes, probably due to the selection bias introduced by the stringent Italian restriction policies concerning subjects who received less than three doses.
While the effectiveness of these vaccines against severe COVID-19 has been documented in several population studies, some primary studies and secondary analyses of serious adverse events reported (a) in the randomized clinical trials of Pfizer and Moderna mRNA COVID-19 vaccines in adults, (b) in the U.S.A. Vaccine Adverse Event Reporting System (VAERS) passive surveillance data, and (c) in the National registries of Denmark, Finland, and Norway, have raised concerns about the safety or risk-benefit profile of COVID-19 vaccination, especially in population subsets with the lowest infection-fatality rate. However, other studies did not show a higher risk of serious adverse events in mRNA vaccine recipients. Most importantly, to date, the only two population-based primary studies with a control group available found significantly lower non-COVID mortality among vaccinated individuals after 28 days and 7.5 months of follow-up.
Both epidemiological and immunological studies showed that COVID-19 vaccination, received either before or after SARS-CoV-2 infection (known as “hybrid immunity”), is able to increase the protection against the virus as compared with natural immunity. No data are available, however, on the potential impact on vaccination safety of having received the vaccine prior or after infection with SARS-CoV-2. We thus further stratified the infected population according to the timing of the infection (Table S15), finding no substantial differences in the overall results between the individuals who were infected before or after vaccination.
As mentioned, while the results were homogeneous for the infected population, the incidence of several outcomes, including death and total PVR-SAEs, was substantially higher among uninfected subjects who received one or two vaccine doses, as compared to those who received three of more doses. This counterintuitive finding may be explained, at least in part, by selection bias. Indeed, during the pandemic, millions of Italians were obliged to receive three vaccine doses to retain their job or access a number of environments (including universities, hospitals, and public places). However, subjects who were infected with SARS-CoV-2 were granted a six-month extension, after which they were mandated to receive only one vaccine dose. As a result, two scenarios emerged. On one side, among uninfected subjects, given the strong pressure to receive three doses, there were only two reasonable categories: those who refused the vaccine in toto and those who wanted to receive three doses, as receiving one or two doses only would not have met the official requirements. This is indeed apparent in the sample: 83.2% of vaccinated uninfected subjects received at least three doses. It may thus be assumed that many of those who received only one or two doses were discouraged from receiving further vaccinations because of the occurrence of a disease, or that they died before receiving the third dose. Thus, these subjects were selectively included in the groups “one dose only” and “two doses only”. In contrast, the infected population did not experience the above selection bias: the vaccination mandate for them was far less stringent, and individuals opted to receive one, two, of three doses according to their personal convictions, which gave rise to very homogeneous results across all vaccine groups. In any case, and most importantly, even among uninfected individuals, the overall comparison, which included all subjects who received at least one dose, showed no increase in the incidence of any outcome among vaccinated subjects, as compared with the unvaccinated.
Dr Paul Offit, a member of the FDA’s Vaccine Advisory Committee, said there is “certainly a causal ink between vaccinations and myocarditis and pericarditis, no doubt about it…it may be the spike protein mimics proteins on heart cells”. This means you inadvertently make an immune response to your own heart muscle.



mah

Avatar utente
Drogato_ di_porno
Storico dell'impulso
Storico dell'impulso
Messaggi: 77925
Iscritto il: 20/06/2002, 2:00

Re: [O.T.] Tra i due litiganti, il terzo COVID

#13144 Messaggio da Drogato_ di_porno »

Immagine
“E' vero che in Russia i bambini mangiavano i comunisti?"
"Magari è il contrario, no?"
"Ecco, mi sembrava strano che c'avessero dei bambini così feroci.”

giorgiograndi
Storico dell'impulso
Storico dell'impulso
Messaggi: 8113
Iscritto il: 13/05/2004, 18:33
Contatta:

Re: [O.T.] Tra i due litiganti, il terzo COVID

#13145 Messaggio da giorgiograndi »

Drogato_ di_porno ha scritto:
03/02/2023, 21:22
Immagine
A parte che Repubblica non può essere chiamato quotidiano di informazione

Per vedere un giornale quelle merde dei giornalisti scriverebbero di qualunque studio che fa contenti i propri lettori e aumenta gli incassi
La scienza e l’informazione (insieme) = erba per pecore
Dai un'occhiata al miei toys: THEWONDERTOYS.COM

Dai un'occhiata al miei video: GIORGIOGRANDI.COM


FOLLOW ME ON TWITTER: @giorgiograndi76

L’unico comunista o marxista buono, è quello in una tomba senza nome

--
Linegoco: "...e se anche fosse (il fallimento della produzione pornografica) chi se ne importa? Nessuno sano di mente si mette a pagare qualcuno solo perché altrimenti fallisce...è ridicolo, ci si dovrebbe impoverire per arricchire altri?"
--
"Usare questo o quello studio come bandiera per sostenere una tesi piuttosto che l'altra è sbagliato."
--
Oscar: Quello che i miei studi non mi hanno ancora detto con certezza e’ se sono gli italiani a generare PD (senza articolo davanti come sinonimo di sostanza di scarto) o se e’ il PD a generare gli italiani.

Ignatius
Bannato
Bannato
Messaggi: 433
Iscritto il: 20/07/2022, 13:29

Re: [O.T.] Tra i due litiganti, il terzo COVID

#13146 Messaggio da Ignatius »

Drogato_ di_porno ha scritto:
03/02/2023, 21:22
Immagine
:lol: :lol: :lol:

HHH
Impulsi superiori
Impulsi superiori
Messaggi: 2165
Iscritto il: 04/06/2012, 18:14

Re: [O.T.] Tra i due litiganti, il terzo COVID

#13147 Messaggio da HHH »

Va beh dai ma è come sparare sulla croce rossa, senza soldi pubblici andrebbero a zappare, è tutta propaganda e terrorismo

Immagine

Ignatius
Bannato
Bannato
Messaggi: 433
Iscritto il: 20/07/2022, 13:29

Re: [O.T.] Tra i due litiganti, il terzo COVID

#13148 Messaggio da Ignatius »

HHH ha scritto:
03/02/2023, 22:20
Va beh dai ma è come sparare sulla croce rossa, senza soldi pubblici andrebbero a zappare, è tutta propaganda e terrorismo

Immagine
:lol:

Avatar utente
dostum
Storico dell'impulso
Storico dell'impulso
Messaggi: 22915
Iscritto il: 18/12/2001, 1:00

Re: [O.T.] Tra i due litiganti, il terzo COVID

#13149 Messaggio da dostum »

MEGLIO LICANTROPI CHE FILANTROPI

Baalkaan hai la machina targata Sassari?

VE LA MERITATE GEGGIA

legionofdoom
Impulsi superiori
Impulsi superiori
Messaggi: 1297
Iscritto il: 23/05/2022, 20:47
Località: Torino

Re: [O.T.] Tra i due litiganti, il terzo COVID

#13150 Messaggio da legionofdoom »

Tra un pò diranno anche che respirare aumenta le emissioni di CO2 :lol:

Avatar utente
pan
Storico dell'impulso
Storico dell'impulso
Messaggi: 19177
Iscritto il: 22/01/2005, 3:12
Località: Terronia settentrionale

Re: [O.T.] Tra i due litiganti, il terzo COVID

#13151 Messaggio da pan »

legionofdoom ha scritto:
04/02/2023, 4:05
Tra un pò diranno anche che respirare aumenta le emissioni di CO2 :lol:
Finalmente sarebbe una notizia vera! :-D
Non seguire le orme degli antichi, ma quello che essi cercarono. (Matsuo Basho,1685) - fa caldo l'Italia è sull'orlo di un baratro e non scopo da mesi (cimmeno 2009) - ...stai su un forum di segaioli; dove pensavi di stare, grande uomo? (sunday silence,2012)

Avatar utente
Floppy Disk
Storico dell'impulso
Storico dell'impulso
Messaggi: 6215
Iscritto il: 17/11/2020, 14:16
Località: Windows XP

Re: [O.T.] Tra i due litiganti, il terzo COVID

#13152 Messaggio da Floppy Disk »

Meno male, mi stavo già preoccupando :)
I'm a humanist. Maybe the last humanist.

In the long run we are all dead.

giorgiograndi
Storico dell'impulso
Storico dell'impulso
Messaggi: 8113
Iscritto il: 13/05/2004, 18:33
Contatta:

Re: [O.T.] Tra i due litiganti, il terzo COVID

#13153 Messaggio da giorgiograndi »

pan ha scritto:
04/02/2023, 7:06
legionofdoom ha scritto:
04/02/2023, 4:05
Tra un pò diranno anche che respirare aumenta le emissioni di CO2 :lol:
Finalmente sarebbe una notizia vera! :-D
Si potrebbe anche aggiungere che gli alberi assorbono co2 (e acqua) creando ossigeno, ma dubito che la maggior parte delle persone si ricordino cosa hanno studiato alle elementari
Dai un'occhiata al miei toys: THEWONDERTOYS.COM

Dai un'occhiata al miei video: GIORGIOGRANDI.COM


FOLLOW ME ON TWITTER: @giorgiograndi76

L’unico comunista o marxista buono, è quello in una tomba senza nome

--
Linegoco: "...e se anche fosse (il fallimento della produzione pornografica) chi se ne importa? Nessuno sano di mente si mette a pagare qualcuno solo perché altrimenti fallisce...è ridicolo, ci si dovrebbe impoverire per arricchire altri?"
--
"Usare questo o quello studio come bandiera per sostenere una tesi piuttosto che l'altra è sbagliato."
--
Oscar: Quello che i miei studi non mi hanno ancora detto con certezza e’ se sono gli italiani a generare PD (senza articolo davanti come sinonimo di sostanza di scarto) o se e’ il PD a generare gli italiani.

Avatar utente
GeishaBalls
Storico dell'impulso
Storico dell'impulso
Messaggi: 12314
Iscritto il: 23/09/2010, 14:34
Località: BO

Re: [O.T.] Tra i due litiganti, il terzo COVID

#13154 Messaggio da GeishaBalls »

giorgiograndi ha scritto:
03/02/2023, 21:50
Drogato_ di_porno ha scritto:
03/02/2023, 21:22
….
A parte che Repubblica non può essere chiamato quotidiano di informazione

Per vedere un giornale quelle merde dei giornalisti scriverebbero di qualunque studio che fa contenti i propri lettori e aumenta gli incassi
La scienza e l’informazione (insieme) = erba per pecore
Giorgio, no, non mettere insieme Scienza e informazione, no. Certo in entrambi i casi ci vuole un ricevente per comprendere il messaggio, ma se i giornali hanno il compito di creare sensazioni forti per vendere, chissenefrega del resto, la Scienza espone i dati che ha al momento relativo alle condizioni osservate, con i limiti delle osservazioni.

Le persone vaccinate sono state meno attente alle altre misure di protezione perché si sentivano tranquille? Oppure le persone non vaccinate sono più propense al rischio e quindi oltre a non essere vaccinati si mettevano più a rischio? La Scienza non può avere dati certi, può fare ipotesi, cioè non dati ma opinioni. Quindi i risultati dipendono dal mix tra effetto del vaccino e resto dei comportamenti ma non si sa in che misura, ed in base al campione i risultati possono essere diversi. Uno con preparazione scientifica lo sa

Il pubblico poco attrezzato, cioè noi, dovrebbe perlomeno rendersi conto che leggiamo i titoli a sensazione e non i rapporti scientifici

Ignatius
Bannato
Bannato
Messaggi: 433
Iscritto il: 20/07/2022, 13:29

Re: [O.T.] Tra i due litiganti, il terzo COVID

#13155 Messaggio da Ignatius »

Ignatius ha scritto:
02/02/2023, 1:56
Floppy Disk ha scritto:
20/01/2023, 19:51
Leggendo la ricerca, mi pare si possa mettere la parola fine a tante chiacchiere, illazioni e teorie più o meno assurde sul fatto che i vaccini siano stati devastanti per la salute e abbiano creato problemi per le generazioni future, quando in realtà hanno fatto l'esatto opposto vista la situazione. Posto un passaggio abbastanza esemplificativo.
[Scopri]Spoiler
In the entire population of an Italian province, followed for an average of 14 months, subjects who received one or more doses of COVID-19 vaccines did not show an increased risk of death from any cause, death unrelated to SARS-CoV-2 infection, or any of the recorded potentially vaccine-related serious adverse events requiring hospitalization. Furthermore, some of the outcomes (all-cause mortality, and incidence of stroke, cardiac arrest, thrombosis, and pulmonary embolism) were significantly less frequent among the vaccinated. These findings were consistent across genders, age-classes, most frequently administered vaccine types, and SARS-CoV-2 infection status and remained so after adjusting for previous episodes of disease and several potential confounders. Importantly, strikingly different results were observed in the uninfected population, between subjects who received three or more doses and those who received only one or two doses. The latter groups showed a significantly higher incidence of most outcomes, probably due to the selection bias introduced by the stringent Italian restriction policies concerning subjects who received less than three doses.
While the effectiveness of these vaccines against severe COVID-19 has been documented in several population studies, some primary studies and secondary analyses of serious adverse events reported (a) in the randomized clinical trials of Pfizer and Moderna mRNA COVID-19 vaccines in adults, (b) in the U.S.A. Vaccine Adverse Event Reporting System (VAERS) passive surveillance data, and (c) in the National registries of Denmark, Finland, and Norway, have raised concerns about the safety or risk-benefit profile of COVID-19 vaccination, especially in population subsets with the lowest infection-fatality rate. However, other studies did not show a higher risk of serious adverse events in mRNA vaccine recipients. Most importantly, to date, the only two population-based primary studies with a control group available found significantly lower non-COVID mortality among vaccinated individuals after 28 days and 7.5 months of follow-up.
Both epidemiological and immunological studies showed that COVID-19 vaccination, received either before or after SARS-CoV-2 infection (known as “hybrid immunity”), is able to increase the protection against the virus as compared with natural immunity. No data are available, however, on the potential impact on vaccination safety of having received the vaccine prior or after infection with SARS-CoV-2. We thus further stratified the infected population according to the timing of the infection (Table S15), finding no substantial differences in the overall results between the individuals who were infected before or after vaccination.
As mentioned, while the results were homogeneous for the infected population, the incidence of several outcomes, including death and total PVR-SAEs, was substantially higher among uninfected subjects who received one or two vaccine doses, as compared to those who received three of more doses. This counterintuitive finding may be explained, at least in part, by selection bias. Indeed, during the pandemic, millions of Italians were obliged to receive three vaccine doses to retain their job or access a number of environments (including universities, hospitals, and public places). However, subjects who were infected with SARS-CoV-2 were granted a six-month extension, after which they were mandated to receive only one vaccine dose. As a result, two scenarios emerged. On one side, among uninfected subjects, given the strong pressure to receive three doses, there were only two reasonable categories: those who refused the vaccine in toto and those who wanted to receive three doses, as receiving one or two doses only would not have met the official requirements. This is indeed apparent in the sample: 83.2% of vaccinated uninfected subjects received at least three doses. It may thus be assumed that many of those who received only one or two doses were discouraged from receiving further vaccinations because of the occurrence of a disease, or that they died before receiving the third dose. Thus, these subjects were selectively included in the groups “one dose only” and “two doses only”. In contrast, the infected population did not experience the above selection bias: the vaccination mandate for them was far less stringent, and individuals opted to receive one, two, of three doses according to their personal convictions, which gave rise to very homogeneous results across all vaccine groups. In any case, and most importantly, even among uninfected individuals, the overall comparison, which included all subjects who received at least one dose, showed no increase in the incidence of any outcome among vaccinated subjects, as compared with the unvaccinated.
Dr Paul Offit, a member of the FDA’s Vaccine Advisory Committee, said there is “certainly a causal ink between vaccinations and myocarditis and pericarditis, no doubt about it…it may be the spike protein mimics proteins on heart cells”. This means you inadvertently make an immune response to your own heart muscle.



mah
Geisha una parola su questo?

Rispondi

Torna a “Ifix Tcen Tcen”